Literature DB >> 17637396

Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results.

J Keith DeWyngaert1, Gabor Jozsef, James Mitchell, Barry Rosenstein, Silvia C Formenti.   

Abstract

PURPOSE: To report the physics and dosimetry results of a trial of accelerated intensity-modulated radiotherapy to the whole breast with a concomitant boost to the tumor bed in patients treated in the prone position. METHODS AND MATERIALS: Patients underwent computed tomography planning and treatment in the prone position on a dedicated treatment platform. The platform has an open aperture on the side to allow for the index breast to fall away from the chest wall. Noncontrast computed tomography images were acquired at 2.5- or 3.75-mm-thick intervals, from the level of the mandible to below the diaphragm. A dose of 40.5 Gy was delivered to the entire breast at 2.7-Gy fractions in 15 fractions. An additional dose of 0.5 Gy was delivered as a concomitant boost to the lumpectomy site, with a 1-cm margin, using inverse planning, for a total dose of 48 Gy in 15 fractions. No more than 10% of the heart and lung volume was allowed to receive >18 and >20 Gy, respectively.
RESULTS: Between September 2003 and August 2005, 91 patients were enrolled in the study. The median volume of heart that received > or =18 Gy was 0.5%, with a maximal value of 4.7%. The median volume of ipsilateral lung that received > or =20 Gy was 0.8%, with a maximum of 7.2%.
CONCLUSION: This technique for whole breast radiotherapy is feasible and enables an accelerated regimen in the prone position while sparing the lung and heart.

Entities:  

Mesh:

Year:  2007        PMID: 17637396     DOI: 10.1016/j.ijrobp.2007.04.018

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  [Distribution of coronary artery stenosis after radiation for breast cancer].

Authors:  F Lohr; F Heggemann
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

2.  Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy.

Authors:  John Ng; Igor Shuryak; Yanguang Xu; K S Clifford Chao; David J Brenner; Ryan J Burri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

3.  Prone breast intensity modulated radiation therapy: 5-year results.

Authors:  Etin-Osa O Osa; Keith DeWyngaert; Daniel Roses; James Speyer; Amber Guth; Deborah Axelrod; Maria Fenton Kerimian; Judith D Goldberg; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-24       Impact factor: 7.038

4.  Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy.

Authors:  E Fernández-Lizarbe; A Montero; A Polo; R Hernanz; R Morís; S Formenti; A Ramos
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

5.  The role of a prone setup in breast radiation therapy.

Authors:  Nelly Huppert; Gabor Jozsef; Keith Dewyngaert; Silvia Chiara Formenti
Journal:  Front Oncol       Date:  2011-10-11       Impact factor: 6.244

6.  Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy.

Authors:  Shahzad Raza; Stella C Lymberis; Raquel Ciervide; Deborah Axelrod; Maria Fenton-Kerimian; Chiara Magnolfi; Barry Rosenstein; J Keith Dewyngaert; Silvia C Formenti
Journal:  Front Oncol       Date:  2012-05-08       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.